Back to User profile » Dr Hemant Phatak

Papers published by Dr Hemant Phatak:

Original Research

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

Zheng Y, Yu T, Mackey RH, Gayle JA, Wassel CL, Phatak H, Kim R

ClinicoEconomics and Outcomes Research 2021, 13:213-226

Published Date: 23 March 2021

Original Research

Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)

Doshi GK, Bhanegaonkar A, Kearney M, Bharmal M, Cislo P, Kim R, Boyd M, Aguilar KM, Phatak H

ClinicoEconomics and Outcomes Research 2020, 12:645-656

Published Date: 5 November 2020

Original Research

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M

ClinicoEconomics and Outcomes Research 2019, 11:659-672

Published Date: 8 November 2019

Original Research

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

Bharmal M, Kearney M, Zheng Y, Phatak H

ClinicoEconomics and Outcomes Research 2019, 11:349-359

Published Date: 22 May 2019